|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Bray F, McCarron P and Parkin DM: The
changing global patterns of female breast cancer incidence and
mortality. Breast Cancer Res. 6:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Althuis MD, Dozier JM, Anderson WF, Devesa
SS and Brinton LA: Global trends in breast cancer incidence and
mortality 1973–1997. Int J Epidemiol. 34:405–412. 2005.PubMed/NCBI
|
|
4
|
Parkin DM and Fernandez LM: Use of
statistics to assess the global burden of breast cancer. Breast J.
12:70–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Madigan MP, Ziegler RG, Benichou J, Byrne
C and Hoover RN: Proportion of breast cancer cases in the United
States explained by well-established risk factors. J Natl Cancer
Inst. 87:1681–1685. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sacco AJ, Kaaks R and Little RE: Breast
cancer: occurrence, risk factors and hormone metabolism. Expert Rev
Anticancer Ther. 3:546–562. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yager JD and Davidson NE: Estrogen
carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collaborative Group on Hormonal Factors in
Breast Cancer. Breast cancer and hormonal contraceptives:
collaborative reanalysis of individual data on 53 297 women with
breast cancer and 100239 women without breast cancer from 54
epidemiological studies. Lancet. 347:1713–1727. 1996. View Article : Google Scholar
|
|
9
|
Hamajima N, Hirose K, Tajima K, et al:
Alcohol, tobacco and breast cancer - collaborative reanalysis of
individual data from 53 epidemiological studies, including 58,515
women with breast cancer and 95,067 women without the disease. Br J
Cancer. 87:1234–1245. 2002. View Article : Google Scholar
|
|
10
|
Krebs EE, Taylor BC, Cauley JA, Stone KL,
Browman PJ and Ensrud KE: Measures of adiposity and risk of breast
cancer in older postmenopausal women. J Am Geriatr Soc. 54:63–69.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsieh CC, Trichopoulos D, Katsouyanni K
and Yuasa S: Age at menarche, age at menopause, height and obesity
as risk factors for breast cancer: associations and interactions in
an international case-control study. Int J Cancer. 46:796–800.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Straif K, Baan R, Grosse Y, Secretan B,
Ghissassi FEL, Bouvard V, Altieri A, Benbrahim-Tallaa L and
Cogliano V: Carcinogenicity of shift-work, painting, and
fire-fighting. Lancet Oncol. 8:1065–1066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagano M, Adachi A, Nakahama K, Nakamura
T, Tamada M, Meyer-Bernstein E, Sehgal A and Shigeyoshi Y: An
abrupt shift in the day/night cycle causes desynchrony in the
mammalian circadian center. J Neurosci. 23:6141–6151.
2003.PubMed/NCBI
|
|
14
|
Romon M, Nuttens MC, Fievet C, et al:
Increased triglyceride levels in shift workers. Am J Med.
93:259–262. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karlsson B, Knutson A and Lindhal B: Is
there an association between shift work and having a metabolic
syndrome? Results from a population based study of 27,485 people.
Occup Environ Med. 58:747–752. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morgan L, Hampton S, Gibbs M and Arendt J:
Circadian aspects of postprandial metabolism. Chronobiol Int.
20:795–808. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al-Naimi S, Hampton SM, Richard P, Tzung C
and Morgan LM: Postprandial metabolic profiles following meals and
snacks eaten during simulated night and day shift work. Chronobiol
Int. 21:937–947. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van Cauter E, Polonsky KS and Scheen AJ:
Roles of circadian rhythmicity and sleep in human glucose
regulation. Endocr Rev. 18:716–738. 1997.PubMed/NCBI
|
|
19
|
Van Cauter E, Plat L and Copinschi G:
Interrelations between sleep and somatotropic axis. Sleep.
21:553–566. 1998.
|
|
20
|
Hennig J, Kieferdorf P, Moritz C, Huwe S
and Netter P: Changes in cortisol secretion during shift work:
implications for tolerance to shift work. Ergonomics. 41:610–621.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lac G and Chamoux A: Biological and
psychological responses to two rapid shiftwork schedules.
Ergonomics. 47:1339–1349. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stevens RG: Electric power use and breast
cancer: a hypothesis. Am J Epidemiol. 125:556–561. 1987.PubMed/NCBI
|
|
23
|
Stevens RG: Artificial lighting in the
industrialized world: circadian disruption and breast cancer.
Cancer Causes Control. 17:501–507. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Megdal SP, Kroenke CH, Laden F, Pukkala E
and Schernhammer ES: Night work and breast cancer risk: a
systematic review and meta-analysis. Eur J Cancer. 41:2023–2032.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kolstad HA: Nightshift work and risk of
breast cancer and other cancers: a critical review of the
epidemiologic evidence. Scand J Work Environ Health. 34:5–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hansen J: Risk of breast cancer after
night and shift work: current evidence and ongoing studies in
Denmark. Cancer Causes Control. 17:531–537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schernhammer E and Schulmeister K: Light
at night and cancer risk. Photochem Photobiol. 79:318. 2004.
View Article : Google Scholar
|
|
28
|
Tynes T, Hannevik M, Andersen A, Vistnes
AI and Haldorsen T: Incidence of breast cancer in Norwegian female
radio and telegraph operators. Cancer Causes Control. 7:197–204.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davis S, Mirick DK and Stevens RG: Night
shift work, light at night, and risk of breast cancer. J Natl
Cancer Inst. 93:1557–1562. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hansen J: Increased breast cancer risk
among women who work predominantly at night. Epidemiology.
12:74–77. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lie JA, Roessink J and Kjaerheim K: Breast
cancer and night work among Norwegian nurses. Cancer Causes
Control. 17:39–44. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hansen J and Stevens RG: Case-control
study of shift-work and breast cancer risk in Danish nurses: impact
of shift systems. Eur J Cancer. Aug 16–2011.(Epub ahead of
print).
|
|
33
|
Lie JA, Kjuus H, Zienolddiny S, Haugen A,
Stevens RG and Kjærheim K: Night work and breast cancer risk among
Norwegian nurses: assessment by different exposure metrics. Am J
Epidemiol. 173:1272–1279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O’Leary ES, Schoenfeld ER, Stevens RG,
Kabat GC, Henderson K, Grimson R, Gammon MD and Leske MC: Shift
work, light at night, and breast cancer on Long Island, New York.
Am J Epidemiol. 164:358–366. 2006.PubMed/NCBI
|
|
35
|
Pesch B, Harth V, Rabstein S, Baisch C,
Schiffermann M, Pallapies D, Bonberg N, Heinze E, Spickenheuer A,
Justenhoven C, et al: Night work and breast cancer: results from
the German GENICA study. Scand J Work Environ Health. 36:134–141.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hansen EJ: The distribution of living
conditions. Main results from the welfare survey. Part I. Theory,
method, and summary Copenhagen: Teknisk Forlag; 1978
|
|
37
|
Gammon MD, Neugut AI, Santella RM,
Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD,
Kabat GC, et al: The Long Island Breast Cancer Study Project:
description of a multi-institutional collaboration to identify
environmental risk factors for breast cancer. Breast Cancer Res
Treat. 74:235–254. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kjaer TK and Hansen J: Cancer incidence
among a large cohort of female Danish registered nurses. Scand J
Work Environ Health. 35:446–453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schernhammer ES, Laden F, Speizer FE,
Willett WC, Hunter DJ, Kawachi I and Colditz GA: Rotating night
shifts and risk of breast cancer in women participating in the
nurses’ health study. J Natl Cancer Inst. 93:1563–1568.
2001.PubMed/NCBI
|
|
40
|
Schernhammer ES, Kroenke CH, Laden F and
Hankinson SE: Night work and risk of breast cancer. Epidemiology.
17:108–111. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schwartzbaum J, Ahlbom A and Feychting M:
Cohort study of cancer risk among male and female shift workers.
Scand J Work Environ Health. 33:336–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li
HL, Rothman N, Gao YT, Zheng W and Chow WH: Night-shift work and
breast cancer risk in a cohort of Chinese women. Am J Epidemiol.
171:953–959. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stampfer MJ, Willett WC, Colditz GA,
Rosner B, Speizer FE and Hennekens CH: A prospective study of
postmenopausal estrogen therapy and coronary heart disease. N Engl
J Med. 313:1044–1049. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Willett WC, Stampfer MJ, Colditz GA,
Rosner BA, Hennekens CH and Speizer FE: Dietary fat and the risk of
breast cancer. N Engl J Med. 316:22–28. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stevens RG, Hansen J, Costa G, Haus E,
Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen
MH, Fritschi L, et al: Considerations of circadian impact for
defining ‘shift work’ in cancer studies: IARC Working Group Report.
Occup Environ Med. 68:154–162. 2011.PubMed/NCBI
|
|
46
|
Klein K, Wegmann H, Athanassenas G,
Hohlweck H and Kuklinski P: Air operations and circadian
performance rhythms. Aviat Space Environ Med. 47:221–230.
1976.PubMed/NCBI
|
|
47
|
Yamazaki S, Numano R, Abe M, Hida A,
Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M and Tei H:
Resetting central and peripheral circadian oscillators in
transgenic rats. Science. 288:682–685. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Haus E and Smolensky M: Biological clocks
and shift work: circadian dysregulation and potential long-term
effects. Cancer Causes Control. 17:489–500. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schibler U: Circadian time keeping: the
daily ups and downs of genes, cells, and organisms. Prog Brain Res.
153:271–282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Balsalobre A, Marcacci L and Schibler U:
Multiple signaling pathways elicit circadian gene expression in
cultured Rat-1 fibroblasts. Curr Biol. 10:1291–1294. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yoo SH, Yamazaki S, Lowrey PL, Shimomura
K, Ko CH, Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ, et al:
PERIOD2::LUCIFERASE real-time reporting of circadian dynamics
reveals persistent circadian oscillations in mouse peripheral
tissues. Poc Natl Acad Sci USA. 101:5339–5346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Miller BH, McDearmon EL, Panda S, Hayes
KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch
JB and Takahashi JS: Circadian and CLOCK-controlled regulation of
the mouse transcriptome and cell proliferation. Proc Natl Acad Sci
USA. 104:3342–3347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lowre PL and Takahashi JS: Mammalian
circadian biology: elucidating genome-wide levels of temporal
organization. Ann Rev Genomics Hum Genet. 5:407–441. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Panda S, Antoch MP, Miller BH, Su AI,
Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS and
Hogenesch JB: Coordinated transcription of key pathways in the
mouse by the circadian clock. Cell. 109:307–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Matsuo T, Yamaguchi S, Mitsui S, Emi A,
Shimoda F and Okamura H: Control mechanism of the circadian clock
for timing of cell division in vivo. Science. 32:255–259. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fu L and Lee CC: The circadian clock:
pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Filipski E, Delaunay F, King VM, Wu MW,
Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH and Francis
L: Effects of chronic jet lag on tumor progression in mice. Cancer
Res. 64:7879–7885. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Filipski E, King VM, Li X, Granda TG,
Mormont MC, Liu X, Claustrat B, Hastings MH and Lévi F: Host
circadian clock as a control point in tumor progression. J Natl
Cancer Inst. 94:690–697. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Butcher GQ, Lee B, Hsieh F and Obrietan K:
Light- and clock-dependent regulation of ribosomal S6 kinase
activity in the suprachiasmatic nucleus. Eur J Neurosci.
19:907–915. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ligresti G, Libra M, Militello L, Clementi
S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA and
Stivala F: Breast cancer: molecular basis and therapeutic
strategies (Review). Mol Med Rep. 1:451–458. 2008.PubMed/NCBI
|
|
62
|
Truchet I, Jozan S, Baron S, Frongia C,
Balaguer P, Richard-Foy H and Valette A: Estrogen and
antiestrogen-dependent regulation of breast cancer cell
proliferation in multicellular spheroids: Influence of cell
microenvironment. Int J Oncol. 32:1033–1039. 2008.PubMed/NCBI
|
|
63
|
Echiburù-Chau C, Roy D and Calaf GM:
Deleterious MnSOD signals lead to abnormal breast cell
proliferation by radiation and estrogen exposure. Int J Oncol.
38:1703–1711. 2011.PubMed/NCBI
|
|
64
|
Schernhammer ES, Rosner B, Willett WC,
Laden F, Colditz GA and Hankinson SE: Epidemiology of urinary
melatonin in women and its relation to other hormones and night
work. Cancer Epidemiol Biomarkers Prev. 13:936–943. 2004.PubMed/NCBI
|
|
65
|
Gail MH, Brinton LA, Byar DP, Corle DK,
Green SB, Schairer C and Mulvihill JJ: Projecting individualized
probabilities of developing breast cancer for white females who are
being examined annually. J Natl Cancer Inst. 81:1879–1886. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Nelson HD, Humphrey LL, Nygren P, Teutsch
SM and Allan JD: Postmenopausal hormone replacement therapy:
scientific review. JAMA. 288:872–881. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Blask DE, Sauer LA and Dauchy RT:
Melatonin as a chronobiotic/anticancer agent: cellular,
biochemical, and molecular mechanisms of action and their
implications for circadian-based cancer therapy. Curr Top Med Chem.
2:113–132. 2002. View Article : Google Scholar
|
|
68
|
Blask DE, Dauchy RT and Sauer LA: Putting
cancer to sleep at night: the neuroendocrine/circadian melatonin
signal. Endocrine. 27:179–188. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Reiter RJ: Mechanisms of cancer inhibition
by melatonin. J Pineal Res. 37:213–214. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Baldwin WS and Barrett JC: Melatonin:
receptor-mediated events that may affect breast and other steroid
hormone-dependent cancers. Mol Carcinog. 21:149–155. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Collins A, Yuan L, Kiefer TL, Cheng Q, Lai
L and Hill SM: Overexpression of the MT1 melatonin receptor in
MCF-7 human breast cancer cells inhibits mammary tumor formation in
nude mice. Cancer Lett. 189:49–57. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Blask DE and Hill SM: Effects of melatonin
on cancer: studies on MCF-7 human breast cancer cells in culture. J
Neural Transm Suppl. 21:433–449. 1986.PubMed/NCBI
|
|
73
|
Cos S, Fernández R, Güézmes A and
Sánchez-Barceló EJ: Influence of melatonin on invasive and
metastatic properties of MCF-7 human breast cancer cells. Cancer
Res. 58:4383–4390. 1998.PubMed/NCBI
|
|
74
|
Leon-Blanco MM, Guerrero JM, Reiter RJ,
Calvo JR and Pozo D: Melatonin inhibits telomerase activity in the
MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res.
35:204–211. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Martínez-Campa C, Alonso-González C,
Mediavilla MD, Cos S, González A, Ramos S and Sanchez-Barcelò EJ:
Melatonin inhibits both ER alpha activation and breast cancer cell
proliferation induced by a metalloestrogen, cadmium. J Pineal Res.
40:291–296. 2006.PubMed/NCBI
|
|
76
|
Martínez-Campa C, Alonso-González C,
Mediavilla MD, Cos S, González A, Ramos S and Sánchez-Barceló EJ:
Melatonin down regulates hTERT expression induced by either natural
estrogens (17b-estradiol) or metalloestrogens (cadmium) in MCF-7
human breast cancer cells. Cancer Lett. 268:272–277. 2008.
|
|
77
|
Molis TM, Spriggs LL, Jupiter Y and Hill
SM: Melatonin modulation of estrogen-regulated proteins, growth
factors, and proto-oncogenes in human breast cancer. J Pineal Res.
18:93–103. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Mediavilla MD, Güezmez A, Ramos S, Kothari
L, Garijo F and Sánchez Barceló EJ: Effects of melatonin on mammary
gland lesions in transgenic mice overexpressing N-ras
protooncogene. J Pineal Res. 22:86–94. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Baturin DA, Alimova IN, Anisimov VN,
Popovich IG, Zabezhinski MA, Provinciali M, Mancini R and
Franceschi C: The effect of light regimen and melatonin on the
development of spontaneous mammary tumors in HER-2/neu transgenic
mice is related to a downregulation of HER-2/neu gene expression.
Neuro Endocrinol Lett. 22:441–447. 2001.PubMed/NCBI
|
